Lappe Mark

EDGAR CIK 0001366074

Inhibrx Biosciences, Inc. - INBX

CEO Director
Chief Executive Officer
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
10
$2.42 M
164,000 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/16/2024
09/16/2024
Buy
13,037 @ $17.13
$223,324 705,548 (1.88%) Indirect - By the Lappe Family Trust
09/12/2024
09/16/2024
Buy
26,963 @ $15.05
$405,793 692,511 (4.05%) Indirect - By the Lappe Family Trust
09/10/2024
09/10/2024
Buy
8,500 @ $15.19
$129,115 665,548 (1.29%) Indirect - By the Lappe Family Trust
09/09/2024
09/10/2024
Buy
9,500 @ $15.21
$144,495 657,048 (1.47%) Indirect - By the Lappe Family Trust
09/06/2024
09/10/2024
Buy
26,000 @ $15.29
$397,540 647,548 (4.18%) Indirect - By the Lappe Family Trust
09/03/2024
09/03/2024
Buy
20,000 @ $15.81
$316,263 165,000 (13.79%) Indirect - By Lappe Descendants' Trust
08/30/2024
09/03/2024
Buy
10,000 @ $14.02
$140,200 145,000 (7.41%) Indirect - By Lappe Descendants' Trust
08/29/2024
09/03/2024
Buy
10,000 @ $14.03
$140,300 135,000 (8.00%) Indirect - By Lappe Descendants' Trust
08/21/2024
08/22/2024
Buy
12,945 @ $12.93
$167,379 54,865 (30.88%) Indirect - The Mark Paul Lappe Roth IRA
08/20/2024
08/22/2024
Buy
27,055 @ $12.97
$350,903 41,920 (182.00%) Indirect - The Mark Paul Lappe Roth IRA